ARRIVENT BIOPHARMA INC. - COMMON STOCK
33.28
12-11月-24 14:24:51
15 分の遅延
株式
-1.06
-3.07%
本日の幅
32.81 - 34.35
ISIN
N/A
ソース
NASDAQ
-
ArriVent BioPharma Reports Second Quarter 2024 Financial Results
14 8 2024 16:01:00 提供 Nasdaq GlobeNewswire
-
12 8 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
ArriVent Announces a Multi-Target ADC Collaboration with Alphamab
05 6 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
ArriVent Appoints John Hohneker, M.D., to its Board of Directors
16 5 2024 16:05:00 提供 Nasdaq GlobeNewswire
- <<
- <
- 1
- >